Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

MeTA introduction


Published on

Presentation by Wilbert Bannenberg, Technical Director, International MeTA Secretariat on MeTA during the 69th FIP Congress, Istanbul, September 2009.

  • Be the first to comment

  • Be the first to like this

MeTA introduction

  1. 1. Wilbert Bannenberg Technical Director International MeTA Secretariat 5 September 2009, FIP 2009 Congress, Istanbul Medicines Transparency Alliance (MeTA) MeTA FIP 05/09/2009
  2. 2. What is MeTA? <ul><li>An international alliance between: </li></ul><ul><ul><li>DFID, World Bank, WHO, private sector, NGOs, professional organisations. </li></ul></ul><ul><li>Alliances in 7 pilot countries to focus on what can be done to increase access to medicines. </li></ul><ul><ul><li>- Government, CSOs and Private Sector </li></ul></ul><ul><li>An International Secretariat to support country work, and, upon request, technical assistance. </li></ul>05/09/2009 MeTA FIP
  3. 3. What does MeTA want to achieve? <ul><li>MeTA goal: to increase access to essential medicines, especially for the poor in developing countries </li></ul><ul><li>Essential medicines still valid concept </li></ul><ul><li>But, after 30 years, 2 billion people are still not having access </li></ul><ul><li>What can we do better? </li></ul>05/09/2009 MeTA FIP
  4. 4. Added value of MeTA? <ul><li>Country led, bottom-up approach </li></ul><ul><li>Multi-stakeholder collaboration </li></ul><ul><li>Improved transparency and disclosure of all players should lead to better information & greater accountability in the supply chain </li></ul>05/09/2009 MeTA FIP
  5. 5. The scope of MeTA <ul><li>Currently 7 countries are piloting MeTA (until September 2010) </li></ul><ul><li>Global collaboration with private sector, NGOs, donors and professional organisations </li></ul>05/09/2009 MeTA FIP
  6. 6. Transparency? <ul><li>Improving information access, scrutiny and use, in order to support the development of viable, efficient medicines markets and supply systems that benefit all developing country consumers </li></ul><ul><li>Transparency = not only disclosure of the price, quality of medicines; but also: </li></ul><ul><ul><li>Jointly use the information to identify barriers, and </li></ul></ul><ul><ul><li>Jointly seek better solutions! </li></ul></ul>MeTA FIP 05/09/2009
  7. 7. Drug Supply – Transparent? Source: SSDS Inc for the World Bank
  8. 8. Transparent? 05/09/2009 MeTA FIP Source: TI Global corruption report 2006
  9. 9. Areas where transparency can help… 05/09/2009 MeTA FIP Source: TI Global corruption report 2006
  10. 10. Transparency in pharmacy practice? <ul><li>Transparency should be an integral part of Good Pharmacy Practice! </li></ul><ul><li>Pharmacists can help in both public and private sector </li></ul><ul><li>Welcome in MeTA! </li></ul>05/09/2009 MeTA FIP
  11. 11. Contact? <ul><li>Wilbert Bannenberg </li></ul><ul><li>[email_address] </li></ul><ul><li>Mobile: +31-6-20873123 </li></ul><ul><li>MeTA website: </li></ul>MeTA FIP 05/09/2009